DNA lipoplexes for gene therapy: a review
DOI:
https://doi.org/10.1590/s2175-97902026e24428Keywords:
Lipoplexes, Gene therapy, Non-viral vectors, Cationic liposomes, Cationic lipidsAbstract
Gene therapy holds substantial promise for the treatment of a wide range of genetic and acquired diseases. Despite its potential, efficient and safe delivery of therapeutic genes into target cells remains a significant challenge. Lipoplexes, lipid-base formulations complexed with nucleic acids, have emerged as an attractive non-viral vector for gene delivery due to their ability to encapsulate and protect nucleic acids and facilitate their delivery into cells. This review focuses on the design, mechanism of action, and structure of lipoplexes for gene therapy and discusses the role of various lipids used in the formation of lipoplexes. Furthermore, we explore the application of lipoplexes in various disease models, cystic fibrosis, and cancers, highlighting recent advances. We conclude that while challenges remain, lipoplexes represent a promising strategy for safe and effective gene therapy.
Downloads
References
Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, et al. Liposome: classification, preparation, and applications. Nanoscale Res Lett. 2013;8:102.
Al-Dosari MS, Gao X. Nonviral gene delivery: principle, limitations, and recent progress. AAPS J. 2009;11(4):671-81.
Alhakamy NA, Curiel DT, Berkland CJ. The era of gene therapy: from preclinical development to clinical application. Drug Discov Today. 2021;26(7):1602-19.
Alton EWFW, Boyd AC, Porteous DJ, Davies G, Davies JC, Griesenbach U, Higgins TE, et al. A Phase I/IIa safety and efficacy study of nebulized liposome-mediated gene therapy for cystic fibrosis supports a multidose trial. Am J Respir Crit Care Med. 2015;192(11):1389-92.
Alton EWFW, Stern M, Farley R, Jaffe A, Chadwick SL, Phillips J, et al. Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet. 1999;353(9157):947-54.
Anderson WF. Human gene therapy. Science. 1992;256(5058):808-13.
Balazs DA, Godbey WT. Liposomes for use in gene delivery. J Drug Deliv. 2011;12.
Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol. 1965;13(1):238-52.
Bansal SK, Rajpoot K, Sreeharsha N, Youngren-Ortiz SR, Anup N, Tekade R. Endosomal escape tendency of drug delivery systems to mediate cytosolic delivery of therapeutics. Future Pharm Prod Dev Res. 2020;227-58.
Barreleiro PCA, May RP, Lindman B. Mechanism of formation of DNA-cationic vesicle complexes. Faraday Discuss. 2002; 122:191-201.
Batzri S, Korn ED. Single bilayer liposomes prepared without sonication. Biochim Biophys Acta. 1973;298(4):1015-19.
Briuglia M-L, Rotella C, McFarlane A, Lamprou DA. Influence of cholesterol on liposome stability and on in vitro drug release. Drug Deliv Transl Res. 2015;5(3):231–42.
Buck J, Mueller D, Mettal U, Ackermann M, Grisch-Chan HM, Thöny B, et al. Improvement of DNA vector delivery of DOTAP lipoplexes by short-chain aminolipids. ACS Omega. 2020;5(38):24724-32.
Campbell MJ. Lipofection reagents prepared by a simple ethanol injection technique. Biotechniques. 1995;18(6):1027-32.
Cheng X, Lee RJ. The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery. Adv Drug Deliv Rev. 2016;99:129-37.
Choosakoonkriang S, Wiethoff CM, Koe GS, Koe JG, Anchordoquy TJ, Middaugh CR. An infrared spectroscopic study of the effect of hydration on cationic lipid/DNA complexes. J Pharm Sci. 2003;92(1):115-30.
Clement J, Kiefer K, Kimpfler A, Garidel P, Peschka-Süss R. Large-scale production of lipoplexes with long shelf-life. Eur J Pharm Biopharm. 2005;59(1):35-43.
ClinicalTrials.gov. Phase I pilot study of gene therapy for cystic fibrosis using cationic liposome mediated gene transfer [Internet]. 2011 [cited 2011 Mar 29]. Available from: https://classic.clinicaltrials.gov/ct2/show/NCT00004471.
ClinicalTrials.gov. Repeated application of gene therapy in CF patients [Internet]. 2015 [cited 2015 Oct 22]. Available from: https://classic.clinicaltrials.gov/ct2/show/NCT01621867.
Clunes MT, Boucher RC. Cystic fibrosis: the mechanisms of pathogenesis of an inherited lung disorder. Drug Discov Today Dis Mech. 2007;4(2):63.
Eastman SJ, Siegel C, Tousignant J, Smith AE, Cheng SH, Scheule RK. Biophysical characterization of cationic lipid complexes. Biochim Biophys Acta Biomembr. 1997;1325(1):41-62.
Elouahabi A, Ruysschaert JM. Formation and intracellular trafficking of lipoplexes and polyplexes. Mol Ther. 2005;11(3):336-47.
El-Zahaby SA, Kaur L, Sharma A, Prasad AG, Wani AK, Singh R, et al. Lipoplexes' structure, preparation, and role in managing different diseases. AAPS PharmSciTech. 2024;25(5).
Even-Chen S, Barenholz Y. DOTAP cationic liposomes prefer relaxed over supercoiled plasmids. Biochim Biophys Acta. 2000 Dec 20;1509(1-2):176-88.
Farhood H, Bottega R, Epand RM, Huang L. Effect of cationic cholesterol derivatives on gene transfer and protein kinase C activity. Biochim Biophys Acta Biomembr. 1992;1111(2):239-46.
Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, et al. Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci U S A. 1987;84(21):7413.
Gao H, Hui KM. Synthesis of a novel series of cationic lipids that can act as efficient gene delivery vehicles through systematic heterocyclic substitution of cholesterol derivatives. Gene Ther. 2001;8(11):855-63.
Gershon H, Ghirlando R, Minsky A, Guttman SB. Mode of formation and structural features of DNA-cationic liposome complexes used for transfection. Biochemistry. 1993;32(28):7143-51.
Gonçalves GAR, Paiva RM. Gene therapy: Advances, challenges and perspectives. Einstein (São Paulo). 2017;15(3):369-75.
Habrant D, Peuziat P, Colombani T, Dallet L, Gehin J, Goudeau E, et al. Design of ionizable lipids to overcome the limiting step of endosomal escape: application in the intracellular delivery of mRNA, DNA, and siRNA. J Med Chem. 2016;59(7):3046-62.
Hayes ME, Drummond DC, Kirpotin DB, Zheng WW, Noble IV CO, Park JW, et al. Genospheres: Self-assembling nucleic acid-lipid nanoparticles suitable for targeted gene delivery. Gene Ther. 2006;13(7):646-51.
Hirlekar R, Jain S, Patel M, Garse H, Kadam V. Hexosomes: A novel drug delivery system. Curr Drug Deliv. 2010;7(1):28-35.
Jeffs LB, Palmer LR, Ambegia EG, Giesbrecht C, Ewanick S, MacLachlan I. A scalable, extrusion-free method for efficient liposomal encapsulation of plasmid DNA. Pharm Res. 2005;22(3):362-72.
Kim N, Duncan GA, Hanes J, Suk JS. Barriers to inhaled gene therapy of obstructive lung diseases: A review. J Control Release. 2016;240:465-88.
Koltover I, Salditt T, Rädler JO, Safinya CR. An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery. Science. 1998;281(5373):78-81.
Kral T, Leblond J, Hof M, Scherman D, Herscovici J, Mignet N. Lipopolythiourea/DNA interaction: A biophysical study. Biophys Chem. 2010;148(1-3):68-73.
Lai E, Van Zanten JH. Real-time monitoring of lipoplex molar mass, size and density. J Control Release. 2002;82(1):149-58.
Leventis R, Silvius JR. Interactions of mammalian cells with lipid dispersions containing novel metabolizable cationic amphiphiles. Biochim Biophys Acta Biomembr. 1990;1023(1):124-32.
Li S, Tan Y, Viroonchatapan E, Pitt BR, Huang L. Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody. Am J Physiol Lung Cell Mol Physiol. 2000;278(3).
Li W, Szoka FC. Lipid-based nanoparticles for nucleic acid delivery. Pharm Res. 2007;24(3):438-49.
Lin Z, Bao M, Yu Z, Xue L, Ju C, Zhang C. The development of tertiary amine cationic lipids for safe and efficient siRNA delivery. Biomater Sci. 2019;7(7):2777-92.
Lindberg MF, Carmoy N, Le Gall T, Fraix A, Berchel M, Lorilleux C, et al. The gene transfection properties of a lipophosphoramidate derivative with two phytanyl chains. Biomaterials. 2012;33(26):6240-53.
Liu J, Guo S, Li Z, Liu L, Gu J. Synthesis and characterization of stearyl protamine and investigation of their complexes with DNA for gene delivery. Colloids Surf B Biointerfaces. 2009;73(1):36-41.
Loisel S, Le Gall C, Doucet L, Ferec C, Floch V. Contribution of plasmid DNA to hepatotoxicity after systemic administration of lipoplexes. Hum Gene Ther. 2001;12(6):685-96.
Lonez C, Lensink MF, Kleiren E, Vanderwinden JM, Ruysschaert JM, Vandenbranden M. Fusogenic activity of cationic lipids and lipid shape distribution. Cell Mol Life Sci. 2010;67(3):483-94.
Luiz MT, Dutra JAp, Tofani LB, Araújo JTC, Di Filippo LD, Marchetti JM, Chorilli M. Targeted liposomes: A nonviral gene delivery system for cancer therapy. Pharmaceutics. 2022;14(4):821.
Ma CC, Wang ZL, Xu T, He ZY, Wei YQ. The approved gene therapy drugs worldwide: From 1998 to 2019. Biotechnol Adv. 2020;40:107502.
Madeira C, Loura LMS, Aires-Barros MR, Prieto M. Fluorescence methods for lipoplex characterization. Biochim Biophys Acta Biomembr. 2011;1808(11):2694–2705.
Manunta MDI, McAnulty RJ, Tagalakis AD, Bottoms SE, Campbell F, Hailes HC, et al. Nebulisation of receptor-targeted nanocomplexes for gene delivery to the airway epithelium. PLoS ONE. 2011;6(10):e26768.
Meisel JW, Gokel GW. A simplified direct lipid mixing lipoplex preparation: Comparison of liposomal-, dimethylsulfoxide-, and ethanol-based methods. Sci Rep. 2016;6(1):27662.
Mo R, Sun Q, Li N, Zhang C. Intracellular delivery and antitumor effects of pH-sensitive liposomes based on zwitterionic oligopeptide lipids. Biomaterials. 2013;34(11):2773–86.
Mok KWC, Cullis PR. Structural and fusogenic properties of cationic liposomes in the presence of plasmid DNA. Biophys J. 1997;73(5):2534-45.
Mout R, Ray M, Lee YW, Scaletti F, Rotello VM. In vivo delivery of CRISPR/Cas9 for therapeutic gene editing: Progress and challenges. Bioconjug Chem. 2017;28(4):880–84.
National Heart, Lung, and Blood Institute. Benefits and risks of genetic therapies [Internet]. Bethesda (MD): National Institutes of Health; 2022 [cited 2023 Oct 30]. Available from: https://internet-prod.nhlbi.nih.gov/health/genetic-therapies/benefits-risks.
Niculescu-Duvaz D, Heyes J, Springer C. Structure-activity relationship in cationic lipid mediated gene transfection. Curr Med Chem. 2005;10(14):1233–61.
Pan X, Veroniaina H, Su N, Sha K, Jiang F, Wu Z, et al. Applications and developments of gene therapy drug delivery systems for genetic diseases. Asian J Pharm Sci. 2021;16(6):687–703.
Patil S, Gao YG, Lin X, Li Y, Dang K, Tian Y, et al. The development of functional non-viral vectors for gene delivery. Int J Mol Sci. 2019;20(21):5491.
Patil YP, Jadhav S. Novel methods for liposome preparation. Chem.Phys.Lipids. 2014;177:8–18.
Ponti F, Campolungo M, Melchiori C, Bono N, Candiani G. Cationic lipids for gene delivery: Many players, one goal. Chem Phys Lipids. 2021;235:105032.
Pozzi D, Caracciolo G. Looking back, moving forward: Lipid nanoparticles as a promising frontier in gene delivery. ACS Pharmacol Transl Sci. 2023;6(11):1561–73.
Rädler JO, Koltover I, Salditt T, Safinya CR. Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes. Science.1997;275(5301):810–14.
Rasoulianboroujeni M., Kupgan G, Moghadam F, Tahriri M, Boughdachi A, Khoshkenar P, et al. Development of a DNA-liposome complex for gene delivery applications. Mater Sci Eng C Mater Biol Appl.2017;75:191-197.
Ren T, Song YK, Zhang G, Liu D. Structural basis of DOTMA for its high intravenous transfection activity in mouse. Gene Ther. 2000;7(9):764–68.
Rietwyk S, Peer D. Next-generation lipids in RNA interference therapeutics. ACS Nano. 2017;11(8):7572-86.
Ross PC, Hui SW. Lipoplex size is a major determinant of in vitro lipofection efficiency. Gene Ther. 1999;6(4):651-9.
Salvati A, Ciani L, Ristori S, Martini G, Masi A, Arcangeli A. Physico-chemical characterization and transfection efficacy of cationic liposomes containing the pEGFP plasmid. Biophys Chem. 2006;121(1):21-9.
Seddon JM. Structure of the inverted hexagonal (HII) phase, and non-lamellar phase transitions of lipids. Biochim Biophys Acta Rev Biomembr. 1990;1031(1):1-69.
Shinkuma S. Advances in gene therapy and their application to skin diseases: a review. J Dermatol Sci. 2021;103(1):2-9.
Simberg D, Danino D, Talmon Y, Minsky A, Ferrari ME, Wheeler CJ, et al. Phase behavior, DNA ordering, and size instability of cationic lipoplexes: relevance to optimal transfection activity. J Biol Chem. 2001;276(50):47453-9.
Simberg D, Weisman S, Talmon Y, Faerman A, Shoshani T, Barenholz Y. The role of organ vascularization and lipoplex-serum initial contact in intravenous murine lipofection. J Biol Chem. 2003;278(41):39858-39865.
Song YK, Liu F, Chu S, Liu D. Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration. Hum Gene Ther. 1997;8(13):1585-94.
Sprugel KH, McPherson JM, Clowes AW, Ross R. Effects of growth factors in vivo. I. Cell ingrowth into porous subcutaneous chambers. Am J Pathol. 1987;129(3):601.
Tan Y, Li S, Pitt BR, Huang L. The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo. Hum Gene Ther. 2004;10(13):2153-61.
Tarahovsky YS, Rakhmanova VA, Epand RM, MacDonald RC. High temperature stabilization of DNA in complexes with cationic lipids. Biophys J. 2002;82(1 Pt 1):264.
Teagle AR, Birchall JC, Hargest R. Gene therapy for pyoderma gangrenosum: optimal transfection conditions and effect of drugs on gene delivery in the HaCaT cell line using cationic liposomes. Skin Pharmacol Physiol. 2016;29(3):119-29.
Tros de Ilarduya C, Sun Y, Düzgüneş N. Gene delivery by lipoplexes and polyplexes. Eur J Pharm Sci. 2010;40(3):159-70.
Warnock JN, Daigre C, Al-Rubeai M. Introduction to viral vectors. Methods Mol Biol. 2011;737:1-25.
Wasungu L, Hoekstra D. Cationic lipids, lipoplexes and intracellular delivery of genes. J Control Release. 2006;116(2):255-64.
Weisman S, Hirsch-Lerner D, Barenholz Y, Talmon Y. Nanostructure of cationic lipid-oligonucleotide complexes. Biophys J. 2004;87(1):609-14.
Witlox MA, Lamfers ML, Wuisman PIJM, Curiel DT, Siegal GP. Evolving gene therapy approaches for osteosarcoma using viral vectors: Review. Bone. 2007;40(4):797-812.
Xu Y, Szoka FC. Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry. 1996;35(18):5616-23.
Yew NS, Scheule RK. Toxicity of cationic lipid-DNA complexes. Adv Genet. 2005;53PA:189-214.
Yew NS, Zhao H, Wu IH, Tousignant JD, Przybylska M, Cheng SH. Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs. Mol Ther. 2000;1(3):255-62.
Zelphati O, Szoka FC. Mechanism of oligonucleotide release from cationic liposomes. Proc Natl Acad Sci USA. 1996;93(21):11493.
Zhou J, Liu J, Cheng CJ, Patel TR, Weller CE, Piepmeier JM, et al. Biodegradable poly(amine-co-ester) terpolymers for targeted gene delivery. Nat Mater. 2012;11(1):82.
Zhou X, Huang L. DNA transfection mediated by cationic liposomes containing lipopolylysine: Characterization and mechanism of action. Biochim Biophys Acta Biomembr. 1994;1189(2):195-203.
Zuidam NJ, Barenholz Y. Electrostatic and structural properties of complexes involving plasmid DNA and cationic lipids commonly used for gene delivery. Biochim Biophys Acta. 1998;1368:115-28.
Downloads
Published
Data Availability Statement
All data is available within the article or its supplementary materials.
Issue
Section
License
Copyright (c) 2026 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on-line journal has open and free access.
